Please use this identifier to cite or link to this item: https://doi.org/10.1038/s41598-018-30290-3
Title: Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch)
Authors: Koh K.J.
Liu Y.
Lim S.H. 
Loh X.J. 
Kang L. 
Lim C.Y.
Phua K.K.L. 
Keywords: messenger RNA
polymer
povidone
animal
C57BL mouse
chemistry
devices
drug delivery system
female
genetics
human
immunotherapy
microinjection
needle
pharmaceutics
procedures
solubility
subcutaneous drug administration
transdermal patch
tumor cell line
Animals
Cell Line, Tumor
Drug Delivery Systems
Female
Humans
Immunotherapy
Injections, Subcutaneous
Mice, Inbred C57BL
Microinjections
Needles
Polymers
Povidone
RNA, Messenger
Solubility
Technology, Pharmaceutical
Transdermal Patch
Issue Date: 2018
Publisher: Nature Publishing Group
Citation: Koh K.J., Liu Y., Lim S.H., Loh X.J., Kang L., Lim C.Y., Phua K.K.L. (2018). Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Scientific Reports 8 (1) : 11842. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-018-30290-3
Abstract: In this paper, we report a proof of concept study on the fabrication, characterization and therapeutic evaluation of in vitro transcribed messenger RNA (mRNA) loaded in a dissolving microneedle patch (RNApatch). We show that low molecular weight polyvinylpyrrolidone (PVP) can directly be used without further purification for RNApatch fabrication with no detectable mRNA degradation. Physical and functional integrity of mRNA stored within the RNApatch are completely preserved for at least 2 weeks under ambient conditions. While the loading of mRNA into RNApatch is limited by the solubility of mRNA in concentrated PVP solution, mechanical strength of RNApatch is not compromised by the presence of mRNA. RNApatch can mediate in vivo transgene expression of mRNA encoding luciferase for up to 72 hours and transfection efficiency and kinetics mediated by RNApatch compares favorably to subcutaneous injection. Interestingly, mRNA transfection efficiency does not correlate with contact surface area but instead increases with deeper delivery depths. In an E.G7-OVA immunotherapy model, RNApatch induces slightly higher cellular and humoral immune responses compared to subcutaneous injection. In conclusion, RNApatch is a viable delivery platform for mRNA and represents an attractive option with significant translation potential for the delivery of mRNA therapeutics. © 2018, The Author(s).
Source Title: Scientific Reports
URI: https://scholarbank.nus.edu.sg/handle/10635/174212
ISSN: 2045-2322
DOI: 10.1038/s41598-018-30290-3
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_s41598-018-30290-3.pdf3.39 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

24
checked on Nov 28, 2021

Page view(s)

101
checked on Nov 18, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.